InfuSystem Holdings, Inc. (NYSE:INFU) has recently received a consensus rating of “Buy” from five research firms that are currently analyzing the stock. According to MarketBeat, one analyst has issued a hold rating, while two analysts assigned a buy rating and another two designated a strong buy rating for the company. The average price target for the stock over the next year is set at $14.50.
Analysts have provided varying insights regarding InfuSystem’s stock performance. Notably, Zacks Research downgraded InfuSystem from a “strong buy” rating to a “hold” rating on October 6, 2023. Conversely, Roth Mkm reaffirmed a “buy” rating and raised its target price from $13.00 to $14.00 in a report dated November 4, 2023.
Current Stock Performance and Market Position
On November 3, 2023, shares of InfuSystem opened at $8.65. The company boasts a market capitalization of $175.91 million, with a price-to-earnings (P/E) ratio of 144.19 and a beta of 1.68. The stock has demonstrated fluctuations with a 50-day moving average of $9.04 and a 200-day moving average of $8.98. Over the past year, the stock has reached a low of $4.61 and a high of $11.04.
InfuSystem maintains strong financial health, evidenced by a current ratio of 1.98 and a quick ratio of 1.59. The company also has a debt-to-equity ratio of 0.50, indicating a balanced approach to leveraging.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a medical technology company focusing on the rental, management, and servicing of infusion pumps and associated devices primarily used for outpatient infusion therapy. The company offers a comprehensive suite of services that facilitate equipment delivery, setup, retrieval, preventive and corrective maintenance, and quality assurance.
InfuSystem’s services aim to streamline clinical operations for hospitals, ambulatory surgery centers, oncology clinics, and private infusion suites, ensuring compliance with safety standards. In addition to its traditional offerings, InfuSystem has recently expanded into remote patient monitoring solutions, enhancing its service portfolio and market reach.
This comprehensive approach positions InfuSystem favorably within the healthcare landscape, reflecting its commitment to innovation and quality in patient care.
